Warts Therapeutics Market to reach US$ 2,314.60 million by 2028 | Top companies Nielsen BioSciences, Scholl's Wellness Company, AIM ImmunoTech

According to our latest study on “Warts Therapeutics Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by Type, Treatment, and End User,” the market is projected to reach US$ 2,314.60 million by 2028 from US$ 1,829.54 million in 2021; it is expected to grow at a CAGR of 3.4% from 2021 to 2028. The report highlights the key factors driving the market growth and prominent players with their developments in the market. The growth of the warts therapeutics market is primarily attributed to the rising prevalence of human papillomavirus infections and recurrence of genital warts, and development of new products. However, poor diagnostics scenario in low-income countries hinders the market growth.

Bausch Health Companies Inc.; Nielsen BioSciences, Inc.; Euro Vital Pharma GmbH, Cipla Inc.; Koninklijke Utermöhlen NV; Novan, Inc.; Scholl's Wellness Company; TEVA PHARMACEUTICAL INDUSTRIES LTD; Verrica Pharmaceuticals Inc.; GlaxoSmithKline plc.; and AIM ImmunoTech Inc are among leading companies operating in the warts therapeutics market.

Request for sample PDF Report Copy @ https://www.theinsightpartners.com/sample/TIPRE00024332/?utm_source=OpenPR&utm_medium=10144

The growth of the market is attributed to rising prevalence of human papillomavirus infections and recurrence of genital warts, and development of new products. However, poor diagnostics scenario in low-income countries restrains the market growth. Warts are skin growth caused by the human papillomaviruses (HPV). There are more than 60 types of HPVs, and several of these tend to cause warts on the skin. Although topical treatments could probably resolve the issue of warts in a few weeks with minimal side effects, they may not be effective all the time. Hence, cryotherapy with liquid nitrogen is a suitable option for treatment, where cure rate is 60–90% and less than 10–20% recurrence rate.

In the US, the demand for warts treatment procedures has reduced due to the shift in focus on COVID-19. The pandemic has been causing havoc in the global supply chains, consumer markets, and economies as a whole. As a result of the measures implemented by governments around the world have negatively impacted the warts therapeutics market growth.

Based on type, the warts therapeutics market is segmented into common warts, genital warts, flat warts, and others. The common warts segment is the largest shareholder in the market; however, the genital warts segment is expected to register the highest CAGR in the market during the forecast period.

Moreover, the recurrence rate for genital warts is high. As per the National Center for Biotechnology Information (NCBI), ~30% of total warts cases globally are expected to regress within the first four months of infection. In addition, HPV infections lead to cervical cancer, and cervical cancer is the fourth most common cancer among women globally. As per the World Health Organization (WHO), ~570,000 new cases of cervical cancer recorded in 2018 with high prevalence in low-income countries. Hence, an increase in the prevalence of HPV infections, leading to a rise in wart cases, and the high recurrence rate of warts are driving the wart therapeutics market growth.

The warts therapeutics market has been segmented on the bases of type, treatment, and end user. Based on type, the market is segmented into common warts, genital warts, flat warts, and others. Based on treatment, the market is segmented into physical destruction, immunomodulation, and chemical destruction. The market for physical destruction is further segmented into cryotherapy, surgical removal, and laser treatment. Moreover, the market for the immunomodulation is further segmented into interferons, retinoids, and zinc. The warts therapeutics market for chemical destruction is further segmented into bleomycin, cantharidin, salicylic acid, and others. By end user, the warts therapeutics market is sub segmented into hospitals, homecare, specialty clinics, and others.

By Geography

North America
US
Canada
Mexico
Europe
France
Germany
UK
Spain
Italy
Rest of Europe
Asia Pacific (APAC)
China
India
Japan
Australia
South Korea
Rest of APAC
Middle East and Africa (MEA)
Saudi Arabia
UAE
South Africa
Rest of MEA
South and Central America (SCAM)
Brazil
Argentina
Rest of SCAM

Buy Complete Report Copy at: https://www.theinsightpartners.com/buy/TIPRE00024332/?utm_source=OpenPR&utm_medium=10144

About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Healthcare, Manufacturing, Automotive and Defense, Food & beverage, Chemical and Materials, Semiconductors. etc.
Contact Us:

Contact Us:
Call: +1-646-491-9876
Email: sales@theinsightpartners.com

This release was published on openPR.